Brazil's Anti-Smoking Project in Amazon: Progress and Challenges

Regulations by 2FIRSTS.ai
May.16.2024
Brazil's Anti-Smoking Project in Amazon: Progress and Challenges
Representatives from Amazonas met at FCecon to discuss advancing the tobacco control project, aiming to reduce smoking rates.

According to Brazilian media reports on May 15th, representatives from the local government of Amazonas and coordinators of national and state-level tobacco control programs met at the Amazonas State Cancer Control Foundation (FCecon) to discuss how to further advance the project. The meeting was attended by Gerson Mourão, director of the Amazonas State Cancer Control Foundation, and representatives from the Amazonas State Health Department (SES-AM).

 

The National Tobacco Control Program (PNCT) is a joint initiative of the Brazilian Ministry of Health and the Brazilian National Cancer Institute (Inca) with a 20-year history. The aim of the program is to reduce smoking rates and smoking- related death rates. In the Amazon region, these activities are primarily carried out by the Amazonas State Cancer Control Center Foundation (FCecon).

 

Aristóteles Alencar, the state coordinator of the Amazonas Tobacco Control Program, stated that Amazonas ranked third in the country for the number of tobacco consumers who quit smoking, achieving remarkable results. He mentioned that the visit from the team of the Brazilian National Cancer Institute (Inca) was to understand the effective actions that have led to Amazonas reaching high quit smoking rates.

 

He pointed out, "Despite the vast expanse of the region and the many logistical challenges, the Brazilian National Cancer Institute (Inca) chose the Amazonas state as its research subject because we have achieved the lowest smoking rates nationwide. Our model can be replicated in other places. The key factors to success include the Amazonas State Cancer Control Center Foundation disseminating information to the public, as well as collaborating with the city and state education departments (Seduc and Semed) to host events promoting anti-smoking campaigns with children, and so on.

 

Alanaca added that, currently, the project is in its second phase. The project aims to expand anti-smoking activities to other areas and places a strong emphasis on understanding the unique environmental factors of each location in order to improve the health of the local population. The purpose of this meeting is to gather the strength of various organizations and individuals to enhance the effectiveness and sustainability of the anti-smoking project. The meeting also aims to raise awareness among regional representatives of the significant economic costs of the diseases and loss of life caused by smoking.

 

This type of epidemic has caused losses of up to 125 billion reais to our country, and we can only recover 10% of that amount from taxes. The amount itself is already unacceptable," expressed Alencar.

 

In addition, consultants Lucas Cabral and Érica Cavalcante from the Brazilian National Cancer Institute emphasized the efforts of institutions such as the Brazilian Ministry of Health (MS) in safeguarding public health and combating tobacco consumption.

 

Lucas Cabral stated: "We need to learn and understand from ourselves as the foundation for improving and integrating public policies, which are implemented by the Brazilian Ministry of Health and the Brazilian National Cancer Institute.

 

The project aims to ensure the strength of domestic tobacco control actions while also taking sustainability into consideration.

 

Due to limited health budget, we first chose five states, one in each region. Now, through discussions with state coordinating bodies, we hope to understand their weaknesses and strengths, and together advance anti-smoking campaigns," explained Kaval Kant.

 

Next, a team from the Brazilian National Cancer Institute and local partners will hold a meeting with professionals responsible for assisting smokers in quitting. They will discuss topics such as tobacco prevention, creating smoke-free environments, and treatment for e-cigarette use.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026
At the 2026 NACS Show, Altria displayed Ploom devices alongside imagery of Marlboro-branded heated tobacco sticks, while also featuring RIOT Energy and Proper Wild non-nicotine products. The booth showcased on! PLUS nicotine pouches, including 12 mg variants not listed among FDA-authorized products as of October 9, and NJOY e-cigarettes. Altria also presented convenience-store traffic figures highlighting its retail presence. 2Firsts examines the company's expanded product portfolio, non-nicotine business activities and the regulatory status of products displayed at the show.
EXPO
Oct.10
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18